Pub Date : 2024-08-01DOI: 10.1016/j.hlc.2024.06.066
{"title":"Non-Vitamin K Antagonist Oral Anticoagulant Use in Underrepresented Populations in Atrial Fibrillation: A Survey of Australian Pharmacist Practice","authors":"","doi":"10.1016/j.hlc.2024.06.066","DOIUrl":"10.1016/j.hlc.2024.06.066","url":null,"abstract":"","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1443950624007248/pdfft?md5=ab151afc4c5c7428f449421f938d1c37&pid=1-s2.0-S1443950624007248-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141951751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-01DOI: 10.1016/j.hlc.2024.06.029
{"title":"The Antifibrotic Effects of Eplerenone in Non-Obstructive Hypertrophic Cardiomyopathy: A Double Blinded, Placebo-Controlled Trial","authors":"","doi":"10.1016/j.hlc.2024.06.029","DOIUrl":"10.1016/j.hlc.2024.06.029","url":null,"abstract":"","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1443950624006875/pdfft?md5=f0c526ff0f7ba23158c415c49b585966&pid=1-s2.0-S1443950624006875-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141959839","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-01DOI: 10.1016/j.hlc.2024.06.027
{"title":"Machine-Learning Based Risk Prediction of Outcomes in Patients Hospitalised With COVID-19 in Australia: The AUS-COVID Score","authors":"","doi":"10.1016/j.hlc.2024.06.027","DOIUrl":"10.1016/j.hlc.2024.06.027","url":null,"abstract":"","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1443950624006851/pdfft?md5=3454ec8d34566daa9046a83cbe0dd851&pid=1-s2.0-S1443950624006851-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141951857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-01DOI: 10.1016/j.hlc.2024.01.036
Aim
Severe COVID-19 can cause acute respiratory distress syndrome, hypoxia, systemic complications, and increased mortality. Pulmonary hypertension (PH) is a major global health issue associated with worsening symptoms and increased mortality. This systematic review aimed to assess the influence of PH onset among COVID-19 patients on all-cause mortality and intensive care unit (ICU) admission.
Method
An unrestricted search of five databases up to June 2022 was undertaken. Pulmonary hypertension was assessed using transthoracic echocardiogram, computed tomography, or right heart catheterisation. After duplicate screening, data extraction, and risk of bias assessment, random effects meta-analyses of odds ratios (OR) and their 95% confidence intervals (CI) were performed for all-cause mortality and ICU admission.
Results
From the 26 studies that were included (3,373 patients, 76% males, median age 62.6 years), PH in COVID-19 patients was significantly associated with higher odds for all-cause mortality (26 studies; OR 3.89; 95% CI 2.85–5.31; p<0.001) and higher odds for ICU admission (six studies; OR 2.50; 95% CI 1.69–3.70; p<0.001). Meta-regression/subgroup analyses by patient demographics, comorbidities, or therapeutic regimens, and sensitivity analyses did not find any differences.
Conclusion
Evidence from observational studies indicates that PH in COVID-19 patients is associated with increased odds of mortality and ICU admission.
{"title":"The Effect of Pulmonary Hypertension on Mortality and Intensive Care Unit Admission in Patients With SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis","authors":"","doi":"10.1016/j.hlc.2024.01.036","DOIUrl":"10.1016/j.hlc.2024.01.036","url":null,"abstract":"<div><h3>Aim</h3><p>Severe COVID-19 can cause acute respiratory distress syndrome, hypoxia, systemic complications, and increased mortality. Pulmonary hypertension (PH) is a major global health issue associated with worsening symptoms and increased mortality. This systematic review aimed to assess the influence of PH onset among COVID-19 patients on all-cause mortality and intensive care unit (ICU) admission.</p></div><div><h3>Method</h3><p>An unrestricted search of five databases up to June 2022 was undertaken. Pulmonary hypertension was assessed using transthoracic echocardiogram, computed tomography, or right heart catheterisation. After duplicate screening, data extraction, and risk of bias assessment, random effects meta-analyses of odds ratios (OR) and their 95% confidence intervals (CI) were performed for all-cause mortality and ICU admission.</p></div><div><h3>Results</h3><p>From the 26 studies that were included (3,373 patients, 76% males, median age 62.6 years), PH in COVID-19 patients was significantly associated with higher odds for all-cause mortality (26 studies; OR 3.89; 95% CI 2.85–5.31; p<0.001) and higher odds for ICU admission (six studies; OR 2.50; 95% CI 1.69–3.70; p<0.001). Meta-regression/subgroup analyses by patient demographics, comorbidities, or therapeutic regimens, and sensitivity analyses did not find any differences.</p></div><div><h3>Conclusion</h3><p>Evidence from observational studies indicates that PH in COVID-19 patients is associated with increased odds of mortality and ICU admission.</p></div>","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1443950624000763/pdfft?md5=dafb30f773f66c215f054b31866b7898&pid=1-s2.0-S1443950624000763-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140794881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-01DOI: 10.1016/j.hlc.2024.02.022
Background
Socio-economic status (SES) has a large impact on health through a complex interplay of upstream, midstream and downstream factors. However, little is known about the predictive role of SES on long-term major adverse cardiovascular, cerebrovascular events, and mortality (MACCE).
Aim
To determine the long-term relationship between SES and MACCE for men and women. The secondary endpoint was to determine the relationship between SES and all-cause mortality.
Method
A total of 3,034 participants (1,494 women and 1,540 men) were assessed at baseline in the Geelong Osteoporosis Study, a large regional Australian population cohort study. Area-based SES was assessed, utilising the Index of Relative Socio-Economic Disadvantage (IRSD) and grouped into quintiles. The primary endpoint, MACCE, was defined as a composite of myocardial infarction, heart failure hospitalisation, malignant arrhythmias, stroke, and all-cause mortality. The secondary endpoint was all-cause mortality. Baseline data including age, sex, smoking status and alcohol use, and comorbidities were collected between 1993–1997 for women, and 2001–2006 for men, with follow-up over 30 and 22 years, respectively. Logistic regression was utilised to assess MACCE and all-cause mortality outcomes across the SES quintiles.
Results
Participants lost to follow-up or with incomplete data collection were excluded leaving 2,173 participants eligible for analysis. SES was associated with MACCE outcomes. Compared with Quintile I (lowest SES stratum), the odds of MACCE for each IRSD stratum were: Quintile II, odds ratio (OR) 0.85 (95% confidence interval [CI] 0.65–1.13); Quintile III, OR 0.69 (95% CI 0.51–0.91); Quintile IV, OR 0.66 (95% CI 0.50–0.88); and, Quintile V, OR 0.55 (95% CI 0.41–0.72). In the adjusted model, an inverse trend was noted, with reducing MACCE outcomes with an increasing SES status; IRSD Quintile II, OR 0.85 (95% CI 0.62–1.17); Quintile III, OR 0.70 (95% CI 0.50–0.97); Quintile IV, OR 0.73 (95% CI 0.52–1.02); and, Quintile V, OR 0.54 (95% CI 0.39–0.74). SES was inversely associated with all-cause mortality; IRSD Quintile II (OR 0.87, 95% CI 0.66–1.16) failed to achieve significance however IRSD Quintile III (OR 0.65, 95% CI 0.48–0.88), Quintile IV (OR 0.59, 95% CI 0.44–0.80) and Quintile V (OR 0.46, 95% CI 0.34–0.62) had a lower risk of mortality compared with Quintile I. In the adjusted model, an inversely proportional trend was noted between SES and all-cause mortality; IRSD Quintile II (OR 0.82, 95% CI 0.59–1.15), IRSD Quintile III (OR 0.63, 95% CI 0.49–0.95), Quintile IV (OR 0.59, 95% CI 0.45–0.90) and Quintile V (OR 0.44, 95% CI 0.31–0.61) had fewer mortality events compared with IRSD Quintile I.
Conclusions
Our research indicates that being part of a lower socio-economic stratum is linked to a higher likelihood of experiencing negative cardiovascular and c
背景:社会经济地位(SES)通过上游、中游和下游因素的复杂相互作用对健康产生巨大影响。然而,人们对社会经济地位对长期主要不良心血管、脑血管事件和死亡率(MACCE)的预测作用知之甚少。次要终点是确定 SES 与全因死亡率之间的关系:方法:在吉隆骨质疏松症研究(Geelong Osteoporosis Study)这一澳大利亚大型地区性人口队列研究中,共对 3034 名参与者(1494 名女性和 1540 名男性)进行了基线评估。利用相对社会经济劣势指数(IRSD)对地区社会经济状况进行了评估,并将其分为五等分。主要终点 MACCE 被定义为心肌梗死、心力衰竭住院、恶性心律失常、中风和全因死亡率的综合。次要终点为全因死亡率。基线数据包括年龄、性别、吸烟和酗酒情况以及合并症,女性的基线数据收集时间为 1993-1997 年,男性的基线数据收集时间为 2001-2006 年,随访时间分别为 30 年和 22 年。利用逻辑回归评估了不同社会经济地位五分位数的MACCE和全因死亡率结果:结果:排除了失去随访或数据收集不完整的参与者,有2173名参与者符合分析条件。SES 与 MACCE 结果相关。与五分位数 I(最低 SES 层)相比,每个 IRSD 层的 MACCE 发生几率分别为五分位数 II 的几率比 (OR) 为 0.85(95% 置信区间 [CI]:0.65-1.13);五分位数 III 的几率比为 0.69(95% 置信区间 [CI]:0.51-0.91);五分位数 IV 的几率比为 0.66(95% 置信区间 [CI]:0.50-0.88);五分位数 V 的几率比为 0.55(95% 置信区间 [CI]:0.41-0.72)。在调整模型中,随着社会经济地位的提高,MACCE结果呈反向趋势:IRSD五分位数II,OR值为0.85(95% CI 0.62-1.17);五分位数III,OR值为0.70(95% CI 0.50-0.97);五分位数IV,OR值为0.73(95% CI 0.52-1.02);五分位数V,OR值为0.54(95% CI 0.39-0.74)。社会经济地位与全因死亡率成反比;IRSD 五分位数 II(OR 0.87,95% CI 0.66-1.16)未达到显著性,但与五分位数 I 相比,IRSD 五分位数 III(OR 0.65,95% CI 0.48-0.88)、五分位数 IV(OR 0.59,95% CI 0.44-0.80)和五分位数 V(OR 0.46,95% CI 0.34-0.62)的死亡风险较低。在调整模型中,SES 与全因死亡率之间呈反比趋势;与 IRSD 五分位数 I 相比,IRSD 五分位数 II(OR 0.82,95% CI 0.59-1.15)、IRSD 五分位数 III(OR 0.63,95% CI 0.49-0.95)、五分位数 IV(OR 0.59,95% CI 0.45-0.90)和五分位数 V(OR 0.44,95% CI 0.31-0.61)的死亡事件较少:我们的研究表明,社会经济地位越低,发生心脑血管负面事件的可能性就越大,同时总死亡率的风险也越高。社会经济地位是心血管疾病和中风长期预后的重要风险分层标志,值得进一步研究。
{"title":"Long-Term Implications of Socioeconomic Status on Major Adverse Cardiovascular, Cerebrovascular Events (MACCE), and All-Cause Mortality","authors":"","doi":"10.1016/j.hlc.2024.02.022","DOIUrl":"10.1016/j.hlc.2024.02.022","url":null,"abstract":"<div><h3>Background</h3><p>Socio-economic status (SES) has a large impact on health through a complex interplay of upstream, midstream and downstream factors. However, little is known about the predictive role of SES on long-term major adverse cardiovascular, cerebrovascular events, and mortality (MACCE).</p></div><div><h3>Aim</h3><p>To determine the long-term relationship between SES and MACCE for men and women. The secondary endpoint was to determine the relationship between SES and all-cause mortality.</p></div><div><h3>Method</h3><p>A total of 3,034 participants (1,494 women and 1,540 men) were assessed at baseline in the Geelong Osteoporosis Study, a large regional Australian population cohort study. Area-based SES was assessed, utilising the Index of Relative Socio-Economic Disadvantage (IRSD) and grouped into quintiles. The primary endpoint, MACCE, was defined as a composite of myocardial infarction, heart failure hospitalisation, malignant arrhythmias, stroke, and all-cause mortality. The secondary endpoint was all-cause mortality. Baseline data including age, sex, smoking status and alcohol use, and comorbidities were collected between 1993–1997 for women, and 2001–2006 for men, with follow-up over 30 and 22 years, respectively. Logistic regression was utilised to assess MACCE and all-cause mortality outcomes across the SES quintiles.</p></div><div><h3>Results</h3><p>Participants lost to follow-up or with incomplete data collection were excluded leaving 2,173 participants eligible for analysis. SES was associated with MACCE outcomes. Compared with Quintile I (lowest SES stratum), the odds of MACCE for each IRSD stratum were: Quintile II, odds ratio (OR) 0.85 (95% confidence interval [CI] 0.65–1.13); Quintile III, OR 0.69 (95% CI 0.51–0.91); Quintile IV, OR 0.66 (95% CI 0.50–0.88); and, Quintile V, OR 0.55 (95% CI 0.41–0.72). In the adjusted model, an inverse trend was noted, with reducing MACCE outcomes with an increasing SES status; IRSD Quintile II, OR 0.85 (95% CI 0.62–1.17); Quintile III, OR 0.70 (95% CI 0.50–0.97); Quintile IV, OR 0.73 (95% CI 0.52–1.02); and, Quintile V, OR 0.54 (95% CI 0.39–0.74). SES was inversely associated with all-cause mortality; IRSD Quintile II (OR 0.87, 95% CI 0.66–1.16) failed to achieve significance however IRSD Quintile III (OR 0.65, 95% CI 0.48–0.88), Quintile IV (OR 0.59, 95% CI 0.44–0.80) and Quintile V (OR 0.46, 95% CI 0.34–0.62) had a lower risk of mortality compared with Quintile I. In the adjusted model, an inversely proportional trend was noted between SES and all-cause mortality; IRSD Quintile II (OR 0.82, 95% CI 0.59–1.15), IRSD Quintile III (OR 0.63, 95% CI 0.49–0.95), Quintile IV (OR 0.59, 95% CI 0.45–0.90) and Quintile V (OR 0.44, 95% CI 0.31–0.61) had fewer mortality events compared with IRSD Quintile I.</p></div><div><h3>Conclusions</h3><p>Our research indicates that being part of a lower socio-economic stratum is linked to a higher likelihood of experiencing negative cardiovascular and c","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S144395062400163X/pdfft?md5=c48e7208a92e219630dc3f2da7e27925&pid=1-s2.0-S144395062400163X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140891984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-01DOI: 10.1016/j.hlc.2024.06.012
{"title":"The Association of Age and Left Atrial Dysfunction in Patients With Atrial Fibrillation","authors":"","doi":"10.1016/j.hlc.2024.06.012","DOIUrl":"10.1016/j.hlc.2024.06.012","url":null,"abstract":"","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S144395062400670X/pdfft?md5=23f879313d5875e4b0e9b980d2dae8b3&pid=1-s2.0-S144395062400670X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141951848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-01DOI: 10.1016/j.hlc.2024.06.028
{"title":"Nox5 in Human Peripheral Blood Mononuclear Cells: A Potential Prognostic Biomarker in Coronary Artery Disease","authors":"","doi":"10.1016/j.hlc.2024.06.028","DOIUrl":"10.1016/j.hlc.2024.06.028","url":null,"abstract":"","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1443950624006863/pdfft?md5=9896d3822f167be60158e2778d9310e3&pid=1-s2.0-S1443950624006863-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141951859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-01DOI: 10.1016/j.hlc.2024.06.007
{"title":"Improved Diagnosis of COVID-19 Vaccine-Associated Myocarditis With Cardiac Scarring Identified by Cardiac Magnetic Resonance Imaging","authors":"","doi":"10.1016/j.hlc.2024.06.007","DOIUrl":"10.1016/j.hlc.2024.06.007","url":null,"abstract":"","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1443950624006656/pdfft?md5=ff606196f71540aba18edfef74ed1e03&pid=1-s2.0-S1443950624006656-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141951745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-01DOI: 10.1016/j.hlc.2024.06.069
{"title":"The Financial Burden of Guideline Directed Medical Therapy (GDMT) for Patients With Heart Failure in Australia","authors":"","doi":"10.1016/j.hlc.2024.06.069","DOIUrl":"10.1016/j.hlc.2024.06.069","url":null,"abstract":"","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1443950624007273/pdfft?md5=c2ddee7229f305da60f9f5c5ee08ef5c&pid=1-s2.0-S1443950624007273-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141951957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}